by Children’s Health Defense Team at the Defender
After the U.S. Food and Drug Administration’s (FDA’s) Emergency Use Authorization (EUA) of COVID-19 vaccines, blood clots were some of the earliest adverse events observed, and abnormal coagulation continues to be one of the most frequent and serious problems reported.
As of mid-September, the Vaccine Adverse Event Reporting System (VAERS) — notorious for capturing only a minuscule proportion of adverse events — had received notification of more than 43,000 blood clotting disorders, including acute-onset problems in young children.
Clotting disorders make the blood clot “too easily,” generating clots that can travel through the bloodstream and increase the risk of heart attacks and strokes, among other potential complications.
Funeral directors and embalmers in the U.S. and U.K. have gone public with shocking descriptions of highly unusual blood clots in up to 85% of the bodies coming under their care — a “massive increase” compared to pre-COVID-19 vaccine times when ordinary-looking clots might be found in 5% to 10% of the deceased.
“In all my years of embalming,…
Continue Reading